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ABSTRACT
Schmitt, Benjamin Allyn. M.S.Egr. Department of Biomedical,
Industrial, and Human Factors Engineering, Wright State
University, 2012. Utility of a Volume-Regulated Drive
System for Direct Mechanical Ventricular Actuation.

Direct Mechanical Ventricular Actuation (DMVA) is a nonblood contacting cardiac assist device that augments
ventricular function. The purpose of this study was to
determine if a volume-regulated “hand pump” drive system
and a pressure-regulated “switch tank” drive system provide
equivalent levels of cardiac support. Canine (n=2) and
swine (n=4) were instrumented for hemodynamic monitoring
and intravascular echocardiography. DMVA support was
assessed during both severe heart failure and fibrillation.
Pump function was evaluated using hemodynamic measures to
calculate stroke work. Myocardial function was assessed
using echocardiographic speckle tracking to quantify strain
rate. Results were compared between groups using paired ttests. There were no significant differences in either pump
function or myocardial strain rates between the hand pump
versus switch tank during support of either the failing or
fibrillating heart. These results suggest functional
equivalency between the two drive system mechanisms that
supports development of an automated volume-regulated
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system, with its corresponding benefits in reduced size,
portability, and potential user-friendly control.
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I. INTRODUCTION
There is currently an unmet need in medicine to provide
rapid and effective circulatory support for victims of
acute cardiac failure or arrest. Pharmacological management
of heart failure with inotropes can augment myocardial
function. However, these drugs also exacerbate the already
increased physiologic demands of heart. Judicious
administration of volume and/or vasodilators can improve
cardiac dynamics through alterations in preload and
afterload, respectively. When these efforts fail, acute
failure enters a downward cycle where the heart
progressively deteriorates as failure becomes increasingly
severe.

In such situations it becomes necessary to directly
supplant the failing heart’s inadequate pumping ability
with mechanical circulatory support (MCS). Clinically
available MCS devices consist of blood pumps. The use of
these devices in combination with an oxygenator (i.e.
cardiopulmonary bypass) allows support of the entire
circulation during open heart surgery or for short-term
resuscitative support.

A wide variety of MCS devices have

also been developed to assist the failing heart and

1

typically rely on the native lung function for blood
oxygenation.

All these devices have common drawbacks (e.g.

blood contact, technically demanding installation) that
limit their feasibility for resuscitative support of the
acutely failing or arrested heart.

Resuscitative cardiac support therapies are predominantly
limited to those defined in the Advanced Cardiac Life
Support algorithms developed by the American Heart
Association.3 These algorithms primarily make use of chest
compressions, defibrillation, and drug interventions to
provide cardiac support. Unfortunately, despite increased
awareness of cardiopulmonary resuscitation techniques among
the public and an emphasis on timely defibrillation, most
patients who suffer cardiac arrest cannot be successfully
resuscitated using these methods.3-10

2

DIRECT MECHANICAL VENTRICULAR ACTUATION

Direct Mechanical Ventricular Actuation (DMVA) is a
MCS device consisting of a polymer cup that augments both
systolic and diastolic ventricular function (Figure 1).11
The DMVA cup is composed of a hard outer shell enclosing a
flexible polymer diaphragm. The ventricles are positioned
inside the cup so the epicardial surface contacts the inner
membrane (Figure 2). The space between the outer shell and
inner diaphragm is pneumatically isolated save for a
connection with a pulsatile driving mechanism. Ventricular
actuation is achieved by cyclic introduction and removal of
air into this space, which act to expand and retract the
flexible diaphragm, respectively. These forces are
translated to the surface of the ventricle after device
attachment. Attachment is achieved by a continuous low
vacuum delivered via an apical port on the cup. This vacuum
both prevents expulsion of the heart during systolic
compression and allows the diaphragm to adhere to the
heart’s epicardial surface. Proper vacuum attachment is
necessary for effective translation of diaphragm forces to
the ventricles.

3

Figure 1 – Representation of the DMVA support system during
diastolic and systolic support. The DMVA system consists of
the DMVA cup, a pulsatile driving mechanism, and a
continuous apical vacuum.

4

Figure 2 – Diagram showing the various features of the DMVA
cup. The cup consists of a hard outer shell and a flexible
inner diaphragm. The ventricles are positioned inside the
cup so their epicardial surface is in contact with the
inner diaphragm. The pulsatile drive system uses air to
expand and retract the flexible diaphragm. A low continuous
vacuum applied to heart apex facilitates a seal between the
epicardium and diaphragm that allows for effective
translation of diaphragm motions to the ventricles.
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DMVA has a inherent advantages when compared to other MCS
devices that make DMVA better suited for cardiac
resuscitation.9 Most clinical MCS devices are best
characterized as blood pumps that reroute blood around the
ventricles. These devices typically require anticoagulants
to prevent thromboembolic complications from interactions
with MCS surfaces. In contrast DMVA only contacts the
heart’s surface, thereby eliminating this need.

Installation of MCS devices is relatively time-consuming
and technically-challenging, sometimes requiring hours and
specialized surgeons. DMVA is simple to install, requiring
one to five minutes in animal12,13 and clinical14-16 studies.
The ability to provide rapid resuscitative circulatory
support suggests DMVA would have a favorable impact on the
time-sensitive nature of cerebral resuscitation. DMVA
installation is dependent on gaining adequate exposure to
the heart’s surface and thereby requires technically
simpler surgical skills compared to other devices, which
require the use of specialized techniques.
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Additionally, there can be the need to install two typical
MCS devices in tandem in order to provide biventricular
support since many are univentricular devices. In contrast
both ventricles are inserted into the DMVA cup, so support
can benefit both the right and left ventricle, as is
frequently necessary.

Many newer MCS devices are continuous flow pumps that use
an impeller to circulate blood throughout the body.2 These
pumps are useful for their enhanced implantability and
reduced power requirements, but sacrifice the enhanced
perfusion provided by physiologic pulsatile flow. DMVA’s
pulsatile blood flow and use of the ventricles in pumping
promote a more physiologic level of perfusion.16

DMVA should be distinguished from simple direct cardiac
compression (DCC) devices, which only apply external
compression forces to the surface of the heart.

A key

weakness of DCC is the lack of diastolic assist and the
subsequent limitations on diastolic filling incurred by
only compressing the heart. This produces stroke volume
insufficiencies and thereby limits the efficacy of such
circulatory support modalities.15 In contrast DMVA augments
both systolic and diastolic function.
7

DMVA DRIVE SYSTEMS

Historically, positive and negative pressure tanks have
been used to generate pulsatile flow for DMVA. In this type
of system, known as the “switch tank”, the cup is actuated
by rapidly alternating between these tanks. However, this
pressure-regulated approach imposes restrictions in both
mobility and compactness that limit use of the device to
established medical centers.

Additionally, control of such

devices has been imprecise and non-intuitive to unfamiliar
users. Recent research in both small and large animal
models has focused on volume-regulated systems using a
hand-operated pneumatic piston known as the “hand pump” to
actuate the DMVA cup. Both approaches are summarized in
Figure 3.
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Figure 3 – (Left) Volume-Regulated (Hand Pump) and (Right)
Pressure-Regulated (Switch Tank) drive systems
demonstrating the means of inducing pneumatic compression
and decompression for systolic and diastolic support,
respectively.
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ECHOCARDIOGRAPHY BACKGROUND

Echocardiography (ECHO) has been a useful tool for
evaluating myocardial function, generally defined by
visually tracking ventricular wall motions. Strain and
strain rate in particular have emerged as quantitative
estimates of myocardial function and contractility.20-22
Strain is the deformation of an object compared to its
original length while strain rate is the rate at which that
relative deformation occurs (Figure 4). Strain rate in
particular has shown promise as a load-independent measure
of myocardial contractility.20,21

To use strain and strain rate as useful parameters,
however, there must be some way to track ventricular wall
motions. The two primary methods of wall tracking are
tissue Doppler imaging and speckle tracking.20 Tissue
Doppler imaging makes use of ultrasound frequency shifts
when reflecting off moving objects to measure instantaneous
tissue velocity gradients in small myocardial segments
(which can be converted to strain rate). However Doppler is
highly angle-dependent (i.e. the beam must be parallel to
the tissue axis), raising questions of reproducibility.

10

Figure 4 – Definition of Lagrangian strain (ε) as the
change in length compared to the original length used in
wall-tracking.
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Speckle tracking uses randomly distributed acoustic markers
(speckles) to uniquely characterize a section of the
ultrasound image.19 Speckles are caused by reflections from
microscopic boundaries in the tissue being analyzed,
meaning each tissue section presents a characteristic
speckle pattern. Each speckle section can be followed over
a number of consecutive frames (necessitating a
sufficiently high frame rate) before tissue motion brings
the speckle section out of frame. Frame-to-frame changes
can be tracked by using sum of absolute difference
algorithms. In addition to its angle-independent nature,
speckle tracking only needs a single cardiac cycle and
analysis can be performed offline using captured twodimensional images. Speckle tracking strains and strain
rates have shown good correlation and agreement with
sonomicrometry when measured under a variety of
conditions.20

Strain and strain rate can be measured along three heart
axes: longitudinal, radial, and circumferential (Figure 5).
Longitudinal strain measurements rely on a long-axis view
of the heart while radial and circumferential strain
measurements rely on a short-axis view. In this study, a
12

long-axis view was better obtainable due to positioning of
the ultrasound transducer to avoid passing the beam through
the air-filled portions of the DMVA cup. The myocardium is
a complex network of overlying layers that contract,
stretch, rotate, and twist in three dimensions, but
longitudinal strain and strain rates (which play are large
part in determining compression and relaxation of the
ventricles assuming constant ventricular volumes) have been
demonstrated as an accurate relative measure of myocardial
function.21
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Figure 5 – Diagram showing different axes of myocardial
strain (L – Longitudinal, R – Radial, C – Circumferential) on
the left ventricle. The longitudinal axis was used for
strain analysis during this study because of its utility in
characterizing myocardial strain and attainability because
the beam does not have to pass through the air-filled
sealed space of the cup.
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PURPOSE

The purpose of this study was to investigate whether there
is functional equivalency between switch tank and hand pump
driven DMVA support when applied to the severely failing or
fibrillated heart.

II. METHODS

The Wright State University Lab Animal Care and Use
Committee approved the experimental protocol, and all
animals were treated in compliance with the Guide for the
Care and Use of Laboratory Animals, published by the
National Institutes of Health, revised 1996.

15

SURGICAL PROTOCOL

Large animal models, comprised of Yorkshire Swine (n = 4)
and canine (n = 2) subjects, were studied. Subjects were
pre-anesthesized with Telazol (6 mg/kg), Xylazine
(3 mg/kg), and Atropine (0.02 mg/kg) followed by tracheal
intubation and mechanical ventilation. Anesthesia was
maintained with 1-2% isoflurane. Vascular access for drug
infusion was achieved through bilateral femoral cutdowns.
Phenylephrine was used to regulate subject arterial
pressure. The subjects were instrumented for left
ventricular, femoral artery, and central venous pressures.
A 10-MHz Acuson AcuNav10F ultrasound catheter was
positioned through the right jugular vein for intravascular
imaging. Two-chamber, left heart long-axis ECHO video clips
encompassing a couple heart cycles were obtained on the
Acuson Sequoia C512 ECHO system.(Note: A summary of
instrumentation is in Table 1). A median sternotomy and
pericardiotomy were performed. An ultrasound flow probe was
placed on the ascending aorta to measure cardiac output.
Surface electrocardiogram, hemodynamics, pulse oximetry,
end-tidal carbon dioxide, and rectal temperature were
monitored using a computer acquisition system.
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Both the hand pump and switch tank drive systems were
instrumented to measure pulsatile and continuous vacuum
pneumatic pressures and pulsatile flow. The displacement of
the hand pump was measured using a string potentiometer.
This setup is schematically shown in Figure 6.

17
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Table 1 – List of devices used for study measurements

Figure 6 – Schematic of experimental setup and data
collection: intravascular echocardiography probe, aortic
flowmeter, arterial pressure transducer, and pneumatic
pressure transducers and flowmeter. The switch tank and
hand pump drive systems were alternated to assess any
differences in support.
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EXPERIMENTAL TIMELINE

After collection of post-sternotomy baseline data, a 9-volt
battery was applied to the epicardial surface to induce
ventricular fibrillation. Following a 5-minute fibrillation
period, DMVA support was provided for 15 minutes. After
this initial support period hearts were defibrillated. If
defibrillation was unsuccessful, DMVA support would
continue for another 15 minutes before another
defibrillation attempt was made. However, if normal cardiac
rhythm was restored, the current cardiac output was
compared to baseline cardiac output to determine the level
of failure. If severe failure was present (cardiac output ≤
60% baseline) after defibrillation, DMVA support was
applied for 15 minutes. If not in severe failure the heart
would remain unsupported for a 15 minute recovery period.
After either completing a supported failure or recovery
period, fibrillation was induced again to restart the cycle
(see Figure 7). For each 15 minute period of support, the
drive system was alternated between the switch tank and
hand pump systems every 3 minutes.

This cycle was repeated

over an experimental duration of 2 hours. Appropriate
physiologic and drive parameters were collected through all
the experimental states: (1) baseline, (2) unsupported
20

fibrillation, (3) unsupported severe heart failure, switch
tank support during (5) fibrillation and (6) failure, hand
pump support during (7) fibrillation and (8) failure, and
(9) recovery. The maximum pressure and rate settings of the
(automated) switch tank system were approximated by the
experimenters operating the manual hand pump system via
visual timing using a computer simulated metronome and
pressure feedback.

ANALYTIC MEASURES

Stroke work (SW) (Equation 1), as a measure of pump
function, was estimated from the product of mean arterial
pressure (MAP) and stroke volume (SV) acquired via
integration of aortic flow (i.e. cardiac output (CO)/heart
rate (HR) in Equation 1).

Equation 1

21
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Figure 7 – Experimental timeline over a two-hour case

Digitized intravascular two-chambered long-axis ECHO video
clips of the left heart were interrogated to assess
myocardial function.

Velocity vector imaging (VVI)

software (Siemens Medical Solutions) was used to calculate
longitudinal myocardial strain rates via speckle tracking.
The endocardial border of a video clip was traced during
end-diastole and played to ensure tracing fidelity to wall
motions (Figure 8). The endocardial border was divided into
six sections representing the basal, mid-wall, and apical
regions of the septal and free-wall sides of the left
ventricle, with each region represented by a strain rate
waveform (Figure 9). Each waveform was characterized by a
peak systolic and diastolic value. A systolic and diastolic
average was computed for the six regions, defined in this
study as global strain rate, to estimate myocardial
function of the left ventricle.18 Paired t-tests were used
to test for significant differences (p < 0.05) between
drive systems.
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RV = Right Ventricle
LV = Left Ventricle
Ao = Aorta

Ao

RV
LV

Septum

Free Wall

Figure 8 – This study used an intravascular
echocardiography probe to capture left ventricular images.
The above image is a characteristic view acquired with
speckle tracking tracing along the endocardial border to
compute tissue velocity, strain, and strain rate as
indicators of myocardial function.
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Figure 9 – Example VVI strain rate results after
endocardial tracing. The heart was divided into six
segments and the peak values in both systole and diastole
were calculated. The averages of these six peaks (global
peak strain rate) for systole and diastole were used an
indicators of overall myocardial function.
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III. RESULTS

As a reminder, the main comparisons being made in this
study are between the hand pump and switch tank in heart
failure and the hand pump and switch tank in ventricular
fibrillation. In this case, failure represents partial
heart functionality while fibrillation represents
negligible function (which is the reason for not including
unsupported fibrillation is the results). Quantitatively,
stroke work, representing overall pump function, and peak
ECHO strain rates, representing myocardial function, were
selected to demonstrate these comparisons.

The stroke work (computed from pressures and flows in
Figure 10) data in Figure 11 shows no significant
difference (p > 0.05) between the two drive systems in
either separate failure or fibrillation comparisons while
significantly higher (p < 0.05) values were obtained during
supported failure compared to unsupported failure.28
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SW = Stroke Work, SV = Stroke Volume, MAP = Mean Arterial Pressure,
CO = Cardiac Output, HR = Heart Rate

Figure 10 – Graph of representative arterial pressure
(dashed line) and aortic flow (black line) waveforms. This
data was used to compute the stroke work of the heart
(product of mean arterial pressure and stroke volume).
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Stroke Work Comparisons
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Figure 11 – Mean heart stroke work estimates for
unsupported and supported heart failure and supported
fibrillation.

There was no significant difference between

switch tank (black) and hand pump (white) support compared
in either failure or fibrillation. There was a significant
increase in stroke work during supported failure compared
to unsupported failure (shaded).
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ECHO strain rate data shows similar trends to that of
stroke work. In comparing the two drive systems in both
failure (Figure 12) and fibrillation (Figure 13), no
significant differences (p > 0.05) were found between the
switch tank and hand pump.17 This strain rate data was
further divided into systolic and diastolic measures, also
displaying non-significance when compared between drive
systems. Support during failure (Figure 12) produced
significant increases (p < 0.05) in max strain rates
compared to unsupported failure.28
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Peak Systolic SR (1/s)
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ECHO Heart Failure Comparison
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*HF Support > HF Unsupported (p < 0.05); HF = Heart Failure, VF = Ventricular
Fibrillation, SR = Strain Rate
Figure 12 – Peak global strain rate magnitudes for systole
and diastole in the failing heart during non-support,
switch tank support, and hand pump support. There was no
significant difference in peak global strain rates when
comparing the two drive systems during either systole or
diastole. There was a significant increase in peak global
strain rate during supported failure compared to
unsupported failure.
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ECHO Fibrillation Comparison
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Figure 13 – Peak global strain rate magnitudes for systole
and diastole during support of fibrillated hearts using the
switch tank and hand pump drive systems. There was no
significant difference in peak global strain rates when
comparing the two drive systems in either systole or
diastole.
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DISCUSSION

ECHO interrogation has been a valuable tool that allows for
a clinically-relevant assessment of device function.
Traditionally, ECHO imaging has been used to visually
evaluate the heart structure and calculate estimates of key
cardiac parameters such as ejection fraction, stroke
volume, cardiac output and stroke work. Speckle tracking
has opened up a whole new level of analysis in that tissue
function can be evaluated directly.

The inclusion of both stoke work and ECHO strain rates was
meant to create a bridge between traditional measures using
pump function and cutting-edge measures using myocardial
function. Pump function measurements are indicators of the
heart’s ability to circulate blood while myocardial
measurements reflect cardiac muscular function, which are
thought to be a more direct measure of cardiac health. Both
variables (stroke work and global max strain rate)
demonstrated predicted significant increases in supported
failure. This demonstrates the utility of DMVA for
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increasing circulatory function during heart failure (in
line with previous work in small animal models).

It is important to note that the max pressure and rate
settings being the same do not necessarily guarantee that
the waveforms have the same shape. The different mechanisms
of pneumatic support may alter the pressure dP/dt profiles
in a significant manner without creating a functional
difference in cardiac support.

The lack of difference between support provided by the two
drive systems in either failure or fibrillation indicates a
functional equivalency at approximately the same max
pressure and rate settings. Given the advantages of a
typical volume-regulated system (practical control features
and compactness) it appears that an automated hand pump
would provide the listed benefits without any significant
performance degradation compared to the established switch
tank system.
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CONCLUSION

This study suggests that there is no significant difference
between DMVA support provided by an established pressureregulated switch tank and an experimental volume-regulated
hand pump. Equivalency was established based on hemodynamic
and cardiac wall motion comparison during support of severe
failure and fibrillation using both drive systems. Given
the lack of significant difference between the drive
systems, the findings suggest that an automated drive
system could be constructed that incorporates the hand pump
and provides equal support to that of the switch tank.
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